By: Sarah Beattie, DNP, APRN-CNP, CDCES The American Diabetes Association estimates that over 8 million people in the United States depend on insulin therapy for survival.¹ Multiple daily injections (MDI) … Continue reading Simplifying Insulin Delivery with CeQur Simplicity
By: Beverly Thomassian GLP-1 receptor agonists and GLP-1/GIP combination therapies have become foundational treatments for type 2 diabetes and obesity. Their benefits now extend well beyond glycemic control and weight … Continue reading Indications for GLP-1/GIP RA Summary Sheet and Beyond!
By: Christine Craig, MS, RD, CDCES Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are now recognized as high-risk health conditions for people living with diabetes. Two … Continue reading Updates in Lifestyle Therapy for MASLD and MASH
AJ is a 52-year-old with type 2 diabetes presents with worsening hyperglycemia despite taking three diabetes medications. AJ says, “No matter what I do, I can’t seem to get my … Continue reading Question of the Week | Clinical Clues to Hypercortisolism
For last week’s practice question, we quizzed participants on Diabetes Type 3c: Misdiagnosis and Clarification 48% of respondents chose the best answer. We want to clarify and share this important … Continue reading Rationale of the Week | Diabetes Type 3c: Misdiagnosis and Clarification
By: Sarah Beattie, DNP, APRN-CNP, CDCES In May 2023, the FDA approved the Beta Bionics iLet Bionic Pancreas insulin pump for individuals 6 years and older. This is the first … Continue reading Beta Bionics iLet Bionic Pancreas: Celebrating Freedom from Carb Counting
By: Sarah Beattie, DNP, APRN-CNP, CDCES In the clinic today, you are seeing L.K., a 28-year-old with type 1 diabetes who was diagnosed at the age of 10. She was … Continue reading Question of the Week | Diabetes Distraction in the Clinic
August 26 @ 11:30 am PST Didn’t Pass the CDCES Exam? You’re Not Alone — Join Our FREE Webinar Didn’t pass the CDCES exam? It’s okay — and you’re not … Continue reading Upcoming Webinars!